Our results showed that the high-risk group with poor survival had a higher expression of T cell exhaustion markers, such as PDCD1/PD1, CTLA4, TIM3, LAG3, VSIR and TIGIT, which lead to tumor immune evasion. The gene discussed is HAVCR2; the disease is neoplasm.